SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-028544
Filing Date
2020-09-28
Accepted
2020-09-28 06:01:51
Documents
4
Period of Report
2020-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea127441-8k_greenwich.htm 8-K 19768
2 UNDERWRITING AGREEMENT, DATED SEPTEMBER 24, 2020 ea127441ex1-1_greenwich.htm EX-1.1 305546
3 PRESS RELEASE DATED SEPTEMBER 24, 2020 ea127441ex99-1_greenwich.htm EX-99.1 11118
4 GRAPHIC ex99-1_001.jpg GRAPHIC 6642
  Complete submission text file 0001213900-20-028544.txt   346865
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 201201899
SIC: 2834 Pharmaceutical Preparations